Page last updated: 2024-12-08

sch 45752

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID160115
CHEMBL ID463175
CHEBI ID181037
SCHEMBL ID1111561
MeSH IDM0057717

Synonyms (31)

Synonym
CHEBI:181037
25908-26-3
nsc-627953
nsc-201419
nsc201419
cephalochromin
MEGXM0_000312
ACON0_000585
NCGC00180856-01
5,6,8-trihydroxy-2-methyl-9-(5,6,8-trihydroxy-2-methyl-4-oxo-2,3-dihydrobenzo[g]chromen-9-yl)-2,3-dihydrobenzo[g]chromen-4-one
nsc627953
5,5',6,6',8,8'-hexahydroxy-2,2'-dimethyl-2,2',3,3'-tetrahydro-4h,4'h-9,9'-bibenzo[g]chromene-4,4'-dione
ACON1_000126
MLS000876993 ,
smr000440611
cid_160115
bdbm50269745
CHEMBL463175 ,
SR-01000758207-2
sr-01000758207
sch 45752
2,2',3,3'-tetrahydro-5,5',6,6',8,8'-hexahydroxy-2,2'-dimethyl-9,9'-bi-4h-naphtho(2,3-b)pyran-4,4'-dione
sch-45752
HMS2270H11
SCHEMBL1111561
HB3825
2,2',3,3'-tetrahydro-5,5',6,6',8,8'-hexahydroxy-2,2'-dimethyl-9,9'-bi[4h-naphtho[2,3-b]pyran]-4,4'-dione
5,5',6,6',8,8'-hexahydroxy-2,2'-dimethyl-2h,2'h-[9,9'-bibenzo[g]chromene]-4,4'(3h,3'h)-dione
DTXSID60948813
compound np-004604
AKOS040739787
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
organooxygen compoundAn organochalcogen compound containing at least one carbon-oxygen bond.
organic heterotricyclic compoundAn organic tricyclic compound in which at least one of the rings of the tricyclic skeleton contains one or more heteroatoms.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (80)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency11.23230.003245.467312,589.2998AID2517; AID2572
Chain A, JmjC domain-containing histone demethylation protein 3AHomo sapiens (human)Potency44.66840.631035.7641100.0000AID504339
Chain A, 2-oxoglutarate OxygenaseHomo sapiens (human)Potency8.91250.177814.390939.8107AID2147
Chain A, ATP-DEPENDENT DNA HELICASE Q1Homo sapiens (human)Potency17.78280.125919.1169125.8920AID2549
Chain A, Ferritin light chainEquus caballus (horse)Potency15.84895.623417.292931.6228AID485281
endonuclease IVEscherichia coliPotency10.00000.707912.432431.6228AID2565
glp-1 receptor, partialHomo sapiens (human)Potency11.22020.01846.806014.1254AID624417
WRNHomo sapiens (human)Potency89.12510.168331.2583100.0000AID651768
ATAD5 protein, partialHomo sapiens (human)Potency8.19610.004110.890331.5287AID504467
USP1 protein, partialHomo sapiens (human)Potency31.62280.031637.5844354.8130AID743255
GLS proteinHomo sapiens (human)Potency2.81840.35487.935539.8107AID624170
TDP1 proteinHomo sapiens (human)Potency1.16590.000811.382244.6684AID686978; AID686979
Microtubule-associated protein tauHomo sapiens (human)Potency12.31290.180013.557439.8107AID1460; AID1468
Smad3Homo sapiens (human)Potency19.95260.00527.809829.0929AID588855
apical membrane antigen 1, AMA1Plasmodium falciparum 3D7Potency7.07950.707912.194339.8107AID720542
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency44.66840.011212.4002100.0000AID1030
regulator of G-protein signaling 4Homo sapiens (human)Potency56.23410.531815.435837.6858AID504845
nonstructural protein 1Influenza A virus (A/WSN/1933(H1N1))Potency15.84890.28189.721235.4813AID2326
67.9K proteinVaccinia virusPotency12.06270.00018.4406100.0000AID720579; AID720580
bromodomain adjacent to zinc finger domain 2BHomo sapiens (human)Potency39.81070.707936.904389.1251AID504333
IDH1Homo sapiens (human)Potency4.61090.005210.865235.4813AID686970
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency2.51190.035520.977089.1251AID504332
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)Homo sapiens (human)Potency25.11890.016525.307841.3999AID602332
lysosomal alpha-glucosidase preproproteinHomo sapiens (human)Potency35.48130.036619.637650.1187AID2100
NPC intracellular cholesterol transporter 1 precursorHomo sapiens (human)Potency1.58490.01262.451825.0177AID485313
vitamin D3 receptor isoform VDRAHomo sapiens (human)Potency79.43280.354828.065989.1251AID504847
chromobox protein homolog 1Homo sapiens (human)Potency28.18380.006026.168889.1251AID540317
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency44.66840.010039.53711,122.0200AID1479
nuclear factor erythroid 2-related factor 2 isoform 2Homo sapiens (human)Potency11.58210.00419.984825.9290AID504444
parathyroid hormone/parathyroid hormone-related peptide receptor precursorHomo sapiens (human)Potency12.58933.548119.542744.6684AID743266
importin subunit beta-1 isoform 1Homo sapiens (human)Potency39.81075.804836.130665.1308AID540253
DNA polymerase betaHomo sapiens (human)Potency17.78280.022421.010289.1251AID485314
mitogen-activated protein kinase 1Homo sapiens (human)Potency5.62340.039816.784239.8107AID1454
flap endonuclease 1Homo sapiens (human)Potency14.12540.133725.412989.1251AID588795
ras-related protein Rab-9AHomo sapiens (human)Potency2.51190.00022.621531.4954AID485297
serine/threonine-protein kinase PLK1Homo sapiens (human)Potency26.67950.168316.404067.0158AID720504
snurportin-1Homo sapiens (human)Potency39.81075.804836.130665.1308AID540253
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)Potency4.46680.425612.059128.1838AID504891
tumor susceptibility gene 101 proteinHomo sapiens (human)Potency79.43280.129810.833132.6090AID493005
GTP-binding nuclear protein Ran isoform 1Homo sapiens (human)Potency39.81075.804816.996225.9290AID540253
DNA polymerase eta isoform 1Homo sapiens (human)Potency10.00000.100028.9256213.3130AID588591
DNA polymerase iota isoform a (long)Homo sapiens (human)Potency1.12200.050127.073689.1251AID588590
urokinase-type plasminogen activator precursorMus musculus (house mouse)Potency10.00000.15855.287912.5893AID540303
plasminogen precursorMus musculus (house mouse)Potency10.00000.15855.287912.5893AID540303
urokinase plasminogen activator surface receptor precursorMus musculus (house mouse)Potency10.00000.15855.287912.5893AID540303
nuclear receptor ROR-gamma isoform 1Mus musculus (house mouse)Potency8.80060.00798.23321,122.0200AID2546; AID2551
lethal(3)malignant brain tumor-like protein 1 isoform IHomo sapiens (human)Potency0.63100.075215.225339.8107AID485360
gemininHomo sapiens (human)Potency9.75420.004611.374133.4983AID624296; AID624297
DNA polymerase kappa isoform 1Homo sapiens (human)Potency14.12540.031622.3146100.0000AID588579
muscleblind-like protein 1 isoform 1Homo sapiens (human)Potency39.81070.00419.962528.1838AID2675
histone acetyltransferase KAT2A isoform 1Homo sapiens (human)Potency35.48130.251215.843239.8107AID504327
neuropeptide S receptor isoform AHomo sapiens (human)Potency10.00000.015812.3113615.5000AID1461
Rap guanine nucleotide exchange factor 3Homo sapiens (human)Potency10.00006.309660.2008112.2020AID720709
Glycoprotein hormones alpha chainHomo sapiens (human)Potency28.18384.46688.344810.0000AID624291
Glutamate receptor 1Rattus norvegicus (Norway rat)Potency19.95260.01418.602439.8107AID2572
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency19.95260.001551.739315,848.9004AID2572
Glutamate receptor 3Rattus norvegicus (Norway rat)Potency19.95260.01418.602439.8107AID2572
Glutamate receptor 4Rattus norvegicus (Norway rat)Potency19.95260.01418.602439.8107AID2572
Guanine nucleotide-binding protein GHomo sapiens (human)Potency28.18381.995325.532750.1187AID624288
TAR DNA-binding protein 43Homo sapiens (human)Potency35.48131.778316.208135.4813AID652104
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
glutathione-S-transferaseSchistosoma japonicumIC50 (µMol)100.00000.850052.5540100.0000AID1117362
Mcl-1Homo sapiens (human)IC50 (µMol)1.49190.40007.134454.0000AID1417
Valosin-containing proteinHomo sapiens (human)IC50 (µMol)46.93000.11006.018728.0000AID1534; AID1544
VifHuman immunodeficiency virus 1IC50 (µMol)0.41000.270034.0015100.0000AID1117319
TatHuman immunodeficiency virus 1IC50 (µMol)7.61800.996039.8009100.0000AID1117361
DNA dC->dU-editing enzyme APOBEC-3G isoform 1Homo sapiens (human)IC50 (µMol)0.41000.270026.3638100.0000AID1117319
Botulinum neurotoxin type A Clostridium botulinum A str. HallIC50 (µMol)29.20002.10002.10002.1000AID673914
Glucagon receptorHomo sapiens (human)IC50 (µMol)20.00000.00660.40172.6000AID333259
M1-family alanyl aminopeptidasePlasmodium falciparum 3D7IC50 (µMol)64.89002.600048.1803128.9800AID1445
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
alkaline phosphatase, intestinalHomo sapiens (human)EC50 (µMol)21.70000.257026.839581.0000AID488873
alkaline phosphatase, tissue-nonspecific isozyme isoform 1 preproproteinHomo sapiens (human)EC50 (µMol)26.70000.227025.090486.8000AID488880
intestinal alkaline phosphatase precursorMus musculus (house mouse)EC50 (µMol)19.10000.382042.469175.0000AID488783
alkaline phosphatase, germ cell type preproproteinHomo sapiens (human)EC50 (µMol)21.10000.550033.733974.0000AID488878
recombinase AMycobacterium tuberculosis H37RvEC50 (µMol)2.03450.018023.2882287.6000AID434968; AID435010
streptokinase A precursorStreptococcus pyogenes M1 GASEC50 (µMol)75.25050.06008.9128130.5170AID1902; AID1914
Estrogen receptorRattus norvegicus (Norway rat)EC50 (µMol)150.00000.006022.3670130.5170AID1914
Estrogen receptor betaRattus norvegicus (Norway rat)EC50 (µMol)150.00000.006022.3670130.5170AID1914
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
replicative DNA helicaseMycobacterium tuberculosis H37RvAC502.24600.057030.7482325.3000AID449749; AID449750
POsterior SegregationCaenorhabditis elegansAC508.29203.298012.464924.6150AID493130
Zinc finger protein mex-5Caenorhabditis elegansAC502.06900.300031.0987106.7000AID449745
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (66)

Processvia Protein(s)Taxonomy
angiogenesisRap guanine nucleotide exchange factor 3Homo sapiens (human)
adaptive immune responseRap guanine nucleotide exchange factor 3Homo sapiens (human)
signal transductionRap guanine nucleotide exchange factor 3Homo sapiens (human)
adenylate cyclase-activating G protein-coupled receptor signaling pathwayRap guanine nucleotide exchange factor 3Homo sapiens (human)
associative learningRap guanine nucleotide exchange factor 3Homo sapiens (human)
Rap protein signal transductionRap guanine nucleotide exchange factor 3Homo sapiens (human)
regulation of actin cytoskeleton organizationRap guanine nucleotide exchange factor 3Homo sapiens (human)
negative regulation of syncytium formation by plasma membrane fusionRap guanine nucleotide exchange factor 3Homo sapiens (human)
intracellular signal transductionRap guanine nucleotide exchange factor 3Homo sapiens (human)
positive regulation of GTPase activityRap guanine nucleotide exchange factor 3Homo sapiens (human)
regulation of angiogenesisRap guanine nucleotide exchange factor 3Homo sapiens (human)
positive regulation of angiogenesisRap guanine nucleotide exchange factor 3Homo sapiens (human)
positive regulation of protein export from nucleusRap guanine nucleotide exchange factor 3Homo sapiens (human)
positive regulation of stress fiber assemblyRap guanine nucleotide exchange factor 3Homo sapiens (human)
regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionRap guanine nucleotide exchange factor 3Homo sapiens (human)
positive regulation of syncytium formation by plasma membrane fusionRap guanine nucleotide exchange factor 3Homo sapiens (human)
establishment of endothelial barrierRap guanine nucleotide exchange factor 3Homo sapiens (human)
cellular response to cAMPRap guanine nucleotide exchange factor 3Homo sapiens (human)
Ras protein signal transductionRap guanine nucleotide exchange factor 3Homo sapiens (human)
regulation of insulin secretionRap guanine nucleotide exchange factor 3Homo sapiens (human)
G protein-coupled receptor signaling pathwayGlycoprotein hormones alpha chainHomo sapiens (human)
positive regulation of cell population proliferationGlycoprotein hormones alpha chainHomo sapiens (human)
hormone-mediated signaling pathwayGlycoprotein hormones alpha chainHomo sapiens (human)
regulation of signaling receptor activityGlycoprotein hormones alpha chainHomo sapiens (human)
positive regulation of steroid biosynthetic processGlycoprotein hormones alpha chainHomo sapiens (human)
positive regulation of cell migrationGlycoprotein hormones alpha chainHomo sapiens (human)
thyroid gland developmentGlycoprotein hormones alpha chainHomo sapiens (human)
luteinizing hormone secretionGlycoprotein hormones alpha chainHomo sapiens (human)
organ growthGlycoprotein hormones alpha chainHomo sapiens (human)
follicle-stimulating hormone signaling pathwayGlycoprotein hormones alpha chainHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIGlycoprotein hormones alpha chainHomo sapiens (human)
negative regulation of organ growthGlycoprotein hormones alpha chainHomo sapiens (human)
follicle-stimulating hormone secretionGlycoprotein hormones alpha chainHomo sapiens (human)
thyroid hormone generationGlycoprotein hormones alpha chainHomo sapiens (human)
cellular response to starvationGlucagon receptorHomo sapiens (human)
positive regulation of gene expressionGlucagon receptorHomo sapiens (human)
generation of precursor metabolites and energyGlucagon receptorHomo sapiens (human)
exocytosisGlucagon receptorHomo sapiens (human)
cell surface receptor signaling pathwayGlucagon receptorHomo sapiens (human)
adenylate cyclase-modulating G protein-coupled receptor signaling pathwayGlucagon receptorHomo sapiens (human)
adenylate cyclase-activating G protein-coupled receptor signaling pathwayGlucagon receptorHomo sapiens (human)
response to nutrientGlucagon receptorHomo sapiens (human)
regulation of blood pressureGlucagon receptorHomo sapiens (human)
hormone-mediated signaling pathwayGlucagon receptorHomo sapiens (human)
glucose homeostasisGlucagon receptorHomo sapiens (human)
response to starvationGlucagon receptorHomo sapiens (human)
regulation of glycogen metabolic processGlucagon receptorHomo sapiens (human)
cellular response to glucagon stimulusGlucagon receptorHomo sapiens (human)
negative regulation of inflammatory response to antigenic stimulusGuanine nucleotide-binding protein GHomo sapiens (human)
renal water homeostasisGuanine nucleotide-binding protein GHomo sapiens (human)
G protein-coupled receptor signaling pathwayGuanine nucleotide-binding protein GHomo sapiens (human)
regulation of insulin secretionGuanine nucleotide-binding protein GHomo sapiens (human)
cellular response to glucagon stimulusGuanine nucleotide-binding protein GHomo sapiens (human)
negative regulation of protein phosphorylationTAR DNA-binding protein 43Homo sapiens (human)
mRNA processingTAR DNA-binding protein 43Homo sapiens (human)
RNA splicingTAR DNA-binding protein 43Homo sapiens (human)
negative regulation of gene expressionTAR DNA-binding protein 43Homo sapiens (human)
regulation of protein stabilityTAR DNA-binding protein 43Homo sapiens (human)
positive regulation of insulin secretionTAR DNA-binding protein 43Homo sapiens (human)
response to endoplasmic reticulum stressTAR DNA-binding protein 43Homo sapiens (human)
positive regulation of protein import into nucleusTAR DNA-binding protein 43Homo sapiens (human)
regulation of circadian rhythmTAR DNA-binding protein 43Homo sapiens (human)
regulation of apoptotic processTAR DNA-binding protein 43Homo sapiens (human)
negative regulation by host of viral transcriptionTAR DNA-binding protein 43Homo sapiens (human)
rhythmic processTAR DNA-binding protein 43Homo sapiens (human)
regulation of cell cycleTAR DNA-binding protein 43Homo sapiens (human)
3'-UTR-mediated mRNA destabilizationTAR DNA-binding protein 43Homo sapiens (human)
3'-UTR-mediated mRNA stabilizationTAR DNA-binding protein 43Homo sapiens (human)
nuclear inner membrane organizationTAR DNA-binding protein 43Homo sapiens (human)
amyloid fibril formationTAR DNA-binding protein 43Homo sapiens (human)
regulation of gene expressionTAR DNA-binding protein 43Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (19)

Processvia Protein(s)Taxonomy
guanyl-nucleotide exchange factor activityRap guanine nucleotide exchange factor 3Homo sapiens (human)
protein bindingRap guanine nucleotide exchange factor 3Homo sapiens (human)
protein domain specific bindingRap guanine nucleotide exchange factor 3Homo sapiens (human)
cAMP bindingRap guanine nucleotide exchange factor 3Homo sapiens (human)
hormone activityGlycoprotein hormones alpha chainHomo sapiens (human)
protein bindingGlycoprotein hormones alpha chainHomo sapiens (human)
follicle-stimulating hormone activityGlycoprotein hormones alpha chainHomo sapiens (human)
glucagon receptor activityGlucagon receptorHomo sapiens (human)
guanyl-nucleotide exchange factor activityGlucagon receptorHomo sapiens (human)
peptide hormone bindingGlucagon receptorHomo sapiens (human)
G protein activityGuanine nucleotide-binding protein GHomo sapiens (human)
adenylate cyclase activator activityGuanine nucleotide-binding protein GHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
double-stranded DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
RNA bindingTAR DNA-binding protein 43Homo sapiens (human)
mRNA 3'-UTR bindingTAR DNA-binding protein 43Homo sapiens (human)
protein bindingTAR DNA-binding protein 43Homo sapiens (human)
lipid bindingTAR DNA-binding protein 43Homo sapiens (human)
identical protein bindingTAR DNA-binding protein 43Homo sapiens (human)
pre-mRNA intronic bindingTAR DNA-binding protein 43Homo sapiens (human)
molecular condensate scaffold activityTAR DNA-binding protein 43Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (23)

Processvia Protein(s)Taxonomy
plasma membraneRap guanine nucleotide exchange factor 3Homo sapiens (human)
cortical actin cytoskeletonRap guanine nucleotide exchange factor 3Homo sapiens (human)
plasma membraneRap guanine nucleotide exchange factor 3Homo sapiens (human)
microvillusRap guanine nucleotide exchange factor 3Homo sapiens (human)
endomembrane systemRap guanine nucleotide exchange factor 3Homo sapiens (human)
membraneRap guanine nucleotide exchange factor 3Homo sapiens (human)
lamellipodiumRap guanine nucleotide exchange factor 3Homo sapiens (human)
filopodiumRap guanine nucleotide exchange factor 3Homo sapiens (human)
extracellular exosomeRap guanine nucleotide exchange factor 3Homo sapiens (human)
extracellular regionGlycoprotein hormones alpha chainHomo sapiens (human)
extracellular spaceGlycoprotein hormones alpha chainHomo sapiens (human)
Golgi lumenGlycoprotein hormones alpha chainHomo sapiens (human)
follicle-stimulating hormone complexGlycoprotein hormones alpha chainHomo sapiens (human)
pituitary gonadotropin complexGlycoprotein hormones alpha chainHomo sapiens (human)
extracellular spaceGlycoprotein hormones alpha chainHomo sapiens (human)
plasma membraneGlutamate receptor 1Rattus norvegicus (Norway rat)
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
endosomeGlucagon receptorHomo sapiens (human)
plasma membraneGlucagon receptorHomo sapiens (human)
membraneGlucagon receptorHomo sapiens (human)
plasma membraneGlucagon receptorHomo sapiens (human)
plasma membraneGuanine nucleotide-binding protein GHomo sapiens (human)
intracellular non-membrane-bounded organelleTAR DNA-binding protein 43Homo sapiens (human)
nucleusTAR DNA-binding protein 43Homo sapiens (human)
nucleoplasmTAR DNA-binding protein 43Homo sapiens (human)
perichromatin fibrilsTAR DNA-binding protein 43Homo sapiens (human)
mitochondrionTAR DNA-binding protein 43Homo sapiens (human)
cytoplasmic stress granuleTAR DNA-binding protein 43Homo sapiens (human)
nuclear speckTAR DNA-binding protein 43Homo sapiens (human)
interchromatin granuleTAR DNA-binding protein 43Homo sapiens (human)
nucleoplasmTAR DNA-binding protein 43Homo sapiens (human)
chromatinTAR DNA-binding protein 43Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (59)

Assay IDTitleYearJournalArticle
AID1138475Cell cycle arrest in human A549 cells assessed as accumulation at G0/G1 phase at 10 uM after 24 hrs using propidium iodide staining by flow cytometry analysis (Rvb = 51 +/- 1.1%)2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Cephalochromin induces G0/G1 cell cycle arrest and apoptosis in A549 human non-small-cell lung cancer cells by inflicting mitochondrial disruption.
AID1138498Induction of apoptosis in human A549 cells assessed as induction of ROS production at 3 uM after 12 hrs using DCF-DA staining by flow cytometry analysis relative to control2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Cephalochromin induces G0/G1 cell cycle arrest and apoptosis in A549 human non-small-cell lung cancer cells by inflicting mitochondrial disruption.
AID1138472Cell cycle arrest in human A549 cells assessed as accumulation at sub-G1 phase at 10 uM after 24 hrs using propidium iodide staining by flow cytometry analysis (Rvb = 2 +/- 0.3%)2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Cephalochromin induces G0/G1 cell cycle arrest and apoptosis in A549 human non-small-cell lung cancer cells by inflicting mitochondrial disruption.
AID1138465Cytotoxicity against human A549 cells after 48 hrs by SRB assay2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Cephalochromin induces G0/G1 cell cycle arrest and apoptosis in A549 human non-small-cell lung cancer cells by inflicting mitochondrial disruption.
AID1138479Cell cycle arrest in human A549 cells assessed as accumulation at S phase at 10 uM after 36 hrs using propidium iodide staining by flow cytometry analysis (Rvb = 9.6 +/- 0.9%)2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Cephalochromin induces G0/G1 cell cycle arrest and apoptosis in A549 human non-small-cell lung cancer cells by inflicting mitochondrial disruption.
AID1138499Induction of apoptosis in human A549 cells assessed as induction of ROS production at 10 uM after 12 hrs using DCF-DA staining by flow cytometry analysis relative to control2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Cephalochromin induces G0/G1 cell cycle arrest and apoptosis in A549 human non-small-cell lung cancer cells by inflicting mitochondrial disruption.
AID1138489Induction of apoptosis in human A549 cells assessed as induction of cleaved PARP protein expression at 10 uM after 26 to 36 hrs by Western blot analysis2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Cephalochromin induces G0/G1 cell cycle arrest and apoptosis in A549 human non-small-cell lung cancer cells by inflicting mitochondrial disruption.
AID1138480Cell cycle arrest in human A549 cells assessed as accumulation at S phase at 10 uM after 48 hrs using propidium iodide staining by flow cytometry analysis (Rvb = 9.5 +/- 0.7%)2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Cephalochromin induces G0/G1 cell cycle arrest and apoptosis in A549 human non-small-cell lung cancer cells by inflicting mitochondrial disruption.
AID1138471Cytotoxicity against human SW1353 cells after 48 hrs by MTT assay2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Cephalochromin induces G0/G1 cell cycle arrest and apoptosis in A549 human non-small-cell lung cancer cells by inflicting mitochondrial disruption.
AID1138484Induction of apoptosis in human A549 cells assessed as DNA level after 24 to 48 hrs using propidium iodide staining by flow cytometry analysis2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Cephalochromin induces G0/G1 cell cycle arrest and apoptosis in A549 human non-small-cell lung cancer cells by inflicting mitochondrial disruption.
AID1138503Induction of apoptosis in human A549 cells assessed as induction of ROS production at 10 uM after 5 hrs using DCF-DA staining by flow cytometry analysis in presence of Tiron2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Cephalochromin induces G0/G1 cell cycle arrest and apoptosis in A549 human non-small-cell lung cancer cells by inflicting mitochondrial disruption.
AID1138477Cell cycle arrest in human A549 cells assessed as accumulation at G0/G1 phase at 10 uM after 48 hrs using propidium iodide staining by flow cytometry analysis (Rvb = 57.3 +/- 0.9%)2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Cephalochromin induces G0/G1 cell cycle arrest and apoptosis in A549 human non-small-cell lung cancer cells by inflicting mitochondrial disruption.
AID1138466Cytotoxicity against human A549 cells after 48 hrs by MTT assay2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Cephalochromin induces G0/G1 cell cycle arrest and apoptosis in A549 human non-small-cell lung cancer cells by inflicting mitochondrial disruption.
AID1138467Cytotoxicity against human Hep3B cells after 48 hrs by MTT assay2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Cephalochromin induces G0/G1 cell cycle arrest and apoptosis in A549 human non-small-cell lung cancer cells by inflicting mitochondrial disruption.
AID673913Inhibition of Clostridium botulinum Hall BoNT/A protease activity using Ac-SNKTRIDEANQRATKML-NH2 as substrate at 20 uM after 5 mins by RP-HPLC analysis2012ACS medicinal chemistry letters, May-10, Volume: 3, Issue:5
Fungal bis-Naphthopyrones as Inhibitors of Botulinum Neurotoxin Serotype A.
AID1138478Cell cycle arrest in human A549 cells assessed as accumulation at S phase at 10 uM after 24 hrs using propidium iodide staining by flow cytometry analysis (Rvb = 12 +/- 1.4%)2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Cephalochromin induces G0/G1 cell cycle arrest and apoptosis in A549 human non-small-cell lung cancer cells by inflicting mitochondrial disruption.
AID1138470Cytotoxicity against human HuH7 cells after 48 hrs by MTT assay2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Cephalochromin induces G0/G1 cell cycle arrest and apoptosis in A549 human non-small-cell lung cancer cells by inflicting mitochondrial disruption.
AID1138488Induction of apoptosis in human A549 cells assessed as proteolytic cleavage of inactive procaspase-8, 9, and 3 into active caspase-8, 9, and 3 at 10 uM by Western blot analysis2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Cephalochromin induces G0/G1 cell cycle arrest and apoptosis in A549 human non-small-cell lung cancer cells by inflicting mitochondrial disruption.
AID1138504Induction of apoptosis in human A549 cells assessed as increase in expression of LC3-II at 10 uM by Western blot analysis2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Cephalochromin induces G0/G1 cell cycle arrest and apoptosis in A549 human non-small-cell lung cancer cells by inflicting mitochondrial disruption.
AID1138490Induction of apoptosis in human A549 cells assessed as reduction of survivin expression at 10 uM by Western blot analysis2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Cephalochromin induces G0/G1 cell cycle arrest and apoptosis in A549 human non-small-cell lung cancer cells by inflicting mitochondrial disruption.
AID1138493Induction of apoptosis in human A549 cells assessed as hypodiploid DNA content at 10 to 20 uM after 48 hrs by flow cytometry analysis in presence of Z-VAD-fmk2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Cephalochromin induces G0/G1 cell cycle arrest and apoptosis in A549 human non-small-cell lung cancer cells by inflicting mitochondrial disruption.
AID1138487Induction of apoptosis in human A549 cells assessed as downregulation of cyclin D1, cyclin E, Cdk 2, and Cdk 4 protein levels after 24 hrs by Western blot analysis2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Cephalochromin induces G0/G1 cell cycle arrest and apoptosis in A549 human non-small-cell lung cancer cells by inflicting mitochondrial disruption.
AID333259Antagonist activity at human glucagon receptor expressed in BHK21 cells assessed as inhibition of glucagon-induced cAMP elevation by RIA2004Journal of natural products, Sep, Volume: 67, Issue:9
BI-32169, a bicyclic 19-peptide with strong glucagon receptor antagonist activity from Streptomyces sp.
AID1138486Induction of apoptosis in human A549 cells assessed as downregulation of cyclin D1, cyclin E, Cdk 2, and Cdk 4 protein levels at 10 uM after 6 to 36 hrs by Western blot analysis2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Cephalochromin induces G0/G1 cell cycle arrest and apoptosis in A549 human non-small-cell lung cancer cells by inflicting mitochondrial disruption.
AID1138496Induction of apoptosis in human A549 cells assessed as induction of ROS production after 12 hrs using DCF-DA staining by flow cytometry analysis2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Cephalochromin induces G0/G1 cell cycle arrest and apoptosis in A549 human non-small-cell lung cancer cells by inflicting mitochondrial disruption.
AID1138502Induction of apoptosis in human A549 cells assessed as induction of ROS production at 10 uM using DCF-DA staining by flow cytometry analysis relative to control2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Cephalochromin induces G0/G1 cell cycle arrest and apoptosis in A549 human non-small-cell lung cancer cells by inflicting mitochondrial disruption.
AID1138494Induction of apoptosis in human A549 cells assessed as loss of mitochondrial membrane potential at 10 to 30 uM after 12 to 24 hrs by flow cytometry analysis2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Cephalochromin induces G0/G1 cell cycle arrest and apoptosis in A549 human non-small-cell lung cancer cells by inflicting mitochondrial disruption.
AID1138501Induction of apoptosis in human A549 cells assessed as induction of ROS production at 5 mM after 12 hrs using DCF-DA staining by flow cytometry analysis relative to control2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Cephalochromin induces G0/G1 cell cycle arrest and apoptosis in A549 human non-small-cell lung cancer cells by inflicting mitochondrial disruption.
AID1138483Cell cycle arrest in human A549 cells assessed as accumulation at G2/M phase at 10 uM after 48 hrs using propidium iodide staining by flow cytometry analysis (Rvb = 31.9 +/- 1.4%)2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Cephalochromin induces G0/G1 cell cycle arrest and apoptosis in A549 human non-small-cell lung cancer cells by inflicting mitochondrial disruption.
AID673915Inhibition of Clostridium botulinum Hall BoNT/A-mediated paralysis in CD1 mouse phrenic nerve hemidiaphragm assessed as time required to 50% loss of twitch tension at 20 uM measured upto 5 hrs (Rvb = 62 mins)2012ACS medicinal chemistry letters, May-10, Volume: 3, Issue:5
Fungal bis-Naphthopyrones as Inhibitors of Botulinum Neurotoxin Serotype A.
AID673912Inhibition of Clostridium botulinum Hall BoNT/A protease activity using Ac-SNKTRIDEANQRATKML-NH2 as substrate at 100 uM after 5 mins by RP-HPLC analysis2012ACS medicinal chemistry letters, May-10, Volume: 3, Issue:5
Fungal bis-Naphthopyrones as Inhibitors of Botulinum Neurotoxin Serotype A.
AID1138481Cell cycle arrest in human A549 cells assessed as accumulation at G2/M phase at 10 uM after 24 hrs using propidium iodide staining by flow cytometry analysis (Rvb = 35.2 +/- 2.3%)2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Cephalochromin induces G0/G1 cell cycle arrest and apoptosis in A549 human non-small-cell lung cancer cells by inflicting mitochondrial disruption.
AID1138476Cell cycle arrest in human A549 cells assessed as accumulation at G0/G1 phase at 10 uM after 36 hrs using propidium iodide staining by flow cytometry analysis (Rvb = 53.1 +/- 1.2%)2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Cephalochromin induces G0/G1 cell cycle arrest and apoptosis in A549 human non-small-cell lung cancer cells by inflicting mitochondrial disruption.
AID1138469Cytotoxicity against human HT1080 cells after 48 hrs by MTT assay2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Cephalochromin induces G0/G1 cell cycle arrest and apoptosis in A549 human non-small-cell lung cancer cells by inflicting mitochondrial disruption.
AID1138468Cytotoxicity against human Caco2 cells after 48 hrs by MTT assay2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Cephalochromin induces G0/G1 cell cycle arrest and apoptosis in A549 human non-small-cell lung cancer cells by inflicting mitochondrial disruption.
AID1138474Cell cycle arrest in human A549 cells assessed as accumulation at sub-G1 phase at 10 uM after 48 hrs using propidium iodide staining by flow cytometry analysis (Rvb = 1.5 +/- 0.1%)2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Cephalochromin induces G0/G1 cell cycle arrest and apoptosis in A549 human non-small-cell lung cancer cells by inflicting mitochondrial disruption.
AID1138492Induction of apoptosis in human A549 cells assessed as reduction of Bad proteins expression at 10 uM after 6 to 36 hrs by Western blot analysis2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Cephalochromin induces G0/G1 cell cycle arrest and apoptosis in A549 human non-small-cell lung cancer cells by inflicting mitochondrial disruption.
AID1138473Cell cycle arrest in human A549 cells assessed as accumulation at sub-G1 phase at 10 uM after 36 hrs using propidium iodide staining by flow cytometry analysis (Rvb = 1.7 +/- 0.4%)2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Cephalochromin induces G0/G1 cell cycle arrest and apoptosis in A549 human non-small-cell lung cancer cells by inflicting mitochondrial disruption.
AID1138500Induction of apoptosis in human A549 cells assessed as induction of ROS production at 30 uM after 12 hrs using DCF-DA staining by flow cytometry analysis relative to control2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Cephalochromin induces G0/G1 cell cycle arrest and apoptosis in A549 human non-small-cell lung cancer cells by inflicting mitochondrial disruption.
AID673914Inhibition of Clostridium botulinum Hall BoNT/A protease activity using Ac-SNKTRIDEANQRATKML-NH2 as substrate after 5 mins by RP-HPLC analysis2012ACS medicinal chemistry letters, May-10, Volume: 3, Issue:5
Fungal bis-Naphthopyrones as Inhibitors of Botulinum Neurotoxin Serotype A.
AID1138497Induction of apoptosis in human A549 cells assessed as induction of ROS production at 1 uM after 12 hrs using DCF-DA staining by flow cytometry analysis relative to control2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Cephalochromin induces G0/G1 cell cycle arrest and apoptosis in A549 human non-small-cell lung cancer cells by inflicting mitochondrial disruption.
AID673916Inhibition of Clostridium botulinum Hall BoNT/A-mediated paralysis in CD1 mouse phrenic nerve hemidiaphragm assessed as time required to 50% loss of twitch tension at 2 uM measured upto 5 hrs (Rvb = 62 mins)2012ACS medicinal chemistry letters, May-10, Volume: 3, Issue:5
Fungal bis-Naphthopyrones as Inhibitors of Botulinum Neurotoxin Serotype A.
AID1138491Induction of apoptosis in human A549 cells assessed as reduction of Bcl-xL expression at 10 uM after 6 to 36 hrs by Western blot analysis2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Cephalochromin induces G0/G1 cell cycle arrest and apoptosis in A549 human non-small-cell lung cancer cells by inflicting mitochondrial disruption.
AID1138482Cell cycle arrest in human A549 cells assessed as accumulation at G2/M phase at 10 uM after 36 hrs using propidium iodide staining by flow cytometry analysis (Rvb = 35.8 +/- 1.8%)2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Cephalochromin induces G0/G1 cell cycle arrest and apoptosis in A549 human non-small-cell lung cancer cells by inflicting mitochondrial disruption.
AID1138485Induction of apoptosis in human A549 cells assessed as DNA level at 3 to 30 uM using propidium iodide staining by flow cytometry analysis2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Cephalochromin induces G0/G1 cell cycle arrest and apoptosis in A549 human non-small-cell lung cancer cells by inflicting mitochondrial disruption.
AID1138495Induction of apoptosis in human A549 cells assessed as loss of mitochondrial membrane potential at 50 uM after 12 to 24 hrs by flow cytometry analysis2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Cephalochromin induces G0/G1 cell cycle arrest and apoptosis in A549 human non-small-cell lung cancer cells by inflicting mitochondrial disruption.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1745845Primary qHTS for Inhibitors of ATXN expression
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (7.69)18.7374
1990's1 (7.69)18.2507
2000's4 (30.77)29.6817
2010's5 (38.46)24.3611
2020's2 (15.38)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.56

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.56 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index5.20 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.56)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]